Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | |
| Cash Flows From Operating Activities | |
| Net Income | -8,435 |
| Accounts payable and accrued liabilities | 66 |
| Other Working Capital | -106 |
| Other Operating Activity | 6,978 |
| Operating Cash Flow | $-1,497 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $N/A |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 1 |
| Other Financing Activity | 17,787 |
| Financing Cash Flow | $17,788 |
| End Cash Position | 16,291 |
| Net Cash Flow | $16,291 |
| Free Cash Flow | |
| Operating Cash Flow | -1,497 |
| Free Cash Flow | -1,497 |